[A case of joint toxicity from pefloxacin in the treatment of nephrotic syndrome in a child].
In order to improve the nephrotic syndrome management, we tried to treat one patient by pefloxacin. A polytenosynotis was noticed during this treatment and motivated it stopping. Remission of proteinuria was obtained after an eleven days treatment. This case give us the opportunity to discuss the possible toxicity of quinolones on joints and the efficacy of pefloxacin in this disease.
Diouf
B
B
Clinique Médicale I, Hôpital A. Le Dantec, Dakar, Sénégal.
Djoneidi
M
M
Niang
A
A
Diallo
S
S
Moreira-Diop
T
T
Bao
O
O
D000293:Adolescent; D000890:Anti-Infective Agents / Q000009:adverse effects*; D000892:Anti-Infective Agents, Urinary / Q000009:adverse effects*; D016903:Drug Monitoring; D006801:Humans; D008297:Male; D009404:Nephrotic Syndrome / Q000188:drug therapy*; D015366:Pefloxacin / Q000009:adverse effects*; D013717:Tenosynovitis / Q000139:chemically induced*
D000890:Anti-Infective Agents; D000892:Anti-Infective Agents, Urinary; D015366:Pefloxacin
Un cas de toxicité articulaire de la pefloxacine dans le traitement du syndrome néphrotique de l'enfant.